No Data
No Data
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Azenta: A Strong Buy on Robust Financial Guidance and Market-Leading Position
Express News | Needham Maintains Buy on Azenta, Maintains $75 Price Target
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
BURLINGTON, Mass., March 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Virtual KeyBanc Life Sciences & MedTech Investor Forum on Tue
In-Depth Examination Of 5 Analyst Recommendations For Azenta
In the preceding three months, 5 analysts have released ratings for Azenta (NASDAQ:AZTA), presenting a wide array of perspectives from bullish to bearish.The table below summarizes their recent rating
Buy Rating Affirmed: Azenta's Strong Financial Outlook and Strategic Growth Trajectory
No Data